Peptide News

Wegovy Pill vs Foundayo: Oral GLP-1s Compared (2026)

The “needle-free” era of weight-loss medicine has arrived. Two pills are now on the US market, and they work in quite different ways.

The two pills at a glance

Wegovy pillFoundayo (orforglipron)
MakerNovo NordiskEli Lilly
FDA approvalDecember 2025 (launched January 2026)April 1, 2026
TypePeptide (oral semaglutide)Non-peptide small molecule
Reported weight lossAbout 14% at 64 weeks on average in trials; higher among people who completed treatmentAbout 12% at 72 weeks at the highest dose
Taking itEmpty stomach, first thing in the morningNo fasting requirement reported

Why the molecule matters

Semaglutide is a peptide and normally breaks down in the gut, so turning it into a pill took years of engineering. Orforglipron is a small molecule that survives digestion without that workaround.

Cost

GoodRx lists introductory pricing that starts around $149 per month for certain Wegovy pill doses, rising to about $299 per month for later fills and other doses, with Foundayo also available from about $149 per month. Prices change often, so check current pricing with your pharmacy or insurer.

Side effects

Both are GLP-1 drugs, so gastrointestinal effects dominate. One comparison reported more dropouts from side effects on orforglipron (about 9%) than on semaglutide (about 5%).

Who might prefer which?

That is a decision for patient and prescriber. Convenience, dosing routine, cardiovascular risk and insurance all matter. The Wegovy pill also carries a cardiovascular risk-reduction indication, like the injection.

What’s next

Oral VK2735 and other candidates are in development.

FAQ

Are pills as effective as injections?

Injectables still tend to produce more weight loss at their highest doses.

Is a GLP-1 pill a peptide?

Oral Wegovy is. Foundayo is not.

Sources: GoodRx GLP-1 pill pages (2026); STAT (March 6, 2026); Join Voy orforglipron comparison; GoodRx 2026 GLP-1 trends.

This article is for general news and education. It is not medical or legal advice. Talk to a licensed clinician about any treatment decision.

Leave a Reply

Your email address will not be published. Required fields are marked *